yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital. .
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful .
.
pm
.